002950 奥美医疗
2026/03 - 三个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入896,09118.12%3,671,5733,326,2922,756,6654,210,503
减:营业总成本774,30817.41%3,139,5092,873,9032,513,9043,557,089
    其中:营业成本603,31614.45%2,621,1612,368,8621,988,0202,793,850
               财务费用24,001-3,074.97%14,5362,33139,903179,282
               资产减值损失842-128.99%(247,343)(32,813)(107,733)(14,783)
公允价值变动收益(8,015)-273.74%7,069(21,907)52,745(57,565)
投资收益4,948-607.68%(17,104)(1,369)(59,628)(102,620)
    其中:对联营企业和合营企业的投资收益(407)-73.87%(27,769)(1,680)9,86924,726
营业利润132,70717.81%319,724458,465169,057525,072
利润总额131,64617.94%309,016454,391169,042484,905
减:所得税费用18,359-26.47%51,86985,59564,82580,262
净利润113,28630.74%257,146368,797104,217404,643
减:非控股权益4,3352,787.68%8,262118(6,183)(2,149)
股东净利润108,95125.95%248,884368,679110,400406,792

市场价值指针
每股收益 (元) *0.17729.58%0.4020.5900.1700.642
每股派息 (元) *----0.1460.0600.0270.060
每股净资产 (元) *5.8395.21%5.6775.4275.0334.897
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容